Day: March 20, 2023

Special meeting of stockholders to approve proposed business combination with Zapp Electric Vehicles Limited to be held on April 12, 2023 Record date for special meeting is February 13, 2023 Upon closing, Zapp Electric Vehicles Group Limited ordinary shares and warrants will be listed on Nasdaq under the new ticker symbols “ZAPP” and “ZAPPW”NEW YORK and LONDON, March 20, 2023 (GLOBE NEWSWIRE) — CIIG Capital Partners II, Inc. (Nasdaq: CIIG) (“CIIG II”) today announced that the U.S. Securities and Exchange Commission (“SEC”) has declared effective the registration statement on Form F-4 (File No. 333-268857) (as amended, the “Registration Statement”) of Zapp Electric Vehicles Group Limited (“Pubco”), which includes a definitive proxy statement/prospectus in connection with CIIG II’s special meeting of stockholders (the “Special...

TORONTO, March 20, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) (NCT04504734) to evaluate the safety and efficacy of Bucillamine, an oral drug with anti-inflammatory and antiviral properties in patients with mild to moderate COVID-19. On March 8th, 2023, the Company announced that it had received the Type C meeting written responses from the FDA to obtain agreement on the proposed protocol endpoints for the Company’s Study. The FDA recommended that the Company’s proposed primary symptom-based endpoint should...

MESA, Ariz., March 20, 2023 (GLOBE NEWSWIRE) — Atlis Motor Vehicles (Nasdaq: AMV), a vertically integrated electric vehicle technology ecosystem company, and US-owned and operated battery cell manufacturer, will host an Investor Town Hall today, Monday, March 20, 2023, at 7:30pm ET / 4:30pm PT. Executives will share key updates regarding the Company’s latest 10-K filing, battery cell mass production trial progress, insight into growing customer demand, and more. Speakers to include:Mark Hanchett, Chief Executive Officer Annie Pratt, President Apoorv Dwivedi, Chief Financial Officer Kate Sieker, Vice President of People David Apps, Vice President, OperationsTo receive a link to the presentation, please sign up here: https://bit.ly/AMVtownhall. About Atlis Motor Vehicles Atlis Motor Vehicles is a technology company driving cutting-edge...

ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the grand opening of a new robotic electrophysiology program at Broward Health Medical Center in Fort Lauderdale, Florida. Broward Health is among the first in the nation, and the first in Florida, to offer the latest Genesis Robotic Magnetic Navigation System to treat heart rhythm disorders. “Advancing patient care is our number one priority, and we are excited to make this unique technology available, expanding our electrophysiology capabilities to treat the most complex heart arrhythmias with heightened precision,” said Ahmed Osman, M.D., Medical Director of Cardiac Electrophysiology. The Genesis RMN system introduces the benefits of robotic precision...

  Monday, March 20, 2023   Dear Shareholders and Investors, There is nervousness in the stock markets. This nervousness does not impact Nordic American Tankers Ltd (NAT). We would like to highlight three observations on the market for oil transportation: Firstly:             We are not affected by the banking crisis that we see. Secondly:        We are not affected by the fluctuations in the oil price. Thirdly:            The market for our vessels continue to be strong  When we experienced uncertainty in the banking world in 2008, the order book for new suezmax tankers the following months and years stood at about 50% of the existing fleet. At this time, the corresponding number is at a low level of 2%, the lowest we have seen for decades. The supply side of our market is protected for years to come, thereby strengthening the fundamentals....

AC Immune at AD/PD™ 2023 to Present New Clinical and Preclinical Data from its Precision Medicine PipelineTen presentations at the International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PDTM) AC Immune’s Chief Medical Officer to participate in expert forum on immunotherapies in Alzheimer’s diseaseLausanne, Switzerland, March 20, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that ten presentations will be delivered at the International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PDTM 2023), taking place in Gothenburg, Sweden, and virtually, on March 28 – April 1, 2023. In addition, Johannes Streffer, M.D., Chief Medical Officer of AC Immune, will join an expert panel to discuss the latest...

EXA TAE Network Map https://exainfra.net/tae-trans-adriatic-express/SAN JOSE, Calif., March 20, 2023 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) announced today that EXA Infrastructure (EXA) has deployed Infinera’s ICE6 800G coherent optical solution on the EXA Trans Adriatic Express (TAE), a submarine cable system linking EXA’s current European footprint to Turkey via Albania and Greece. TAE is a joint venture formed between EXA and Trans Adriatic Pipeline Ag (TAP), the owner of a critical new gas pipeline connecting the Caspian Sea to southern Italy. Completed in 2020, the pipeline connects Melendugno in southern Italy through Albania and Greece to the Turkish border at Kipoi. This project creates a unique fiber optic network connecting Milan, Tirana, Athens, Sofia, and Istanbul with high-quality, high-performance, and ultra-reliable...